Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
TOPGEN
company
About
TOPGEN provides tumor-oriented precision medical testing, cellular immunotherapy, and other services.
- 51 - 100
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- ¥120M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2012
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥145M
TOPGEN has raised a total of
¥145M
in funding over 2 rounds. Their latest funding was raised on
Jul 13, 2020 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 13, 2020 | Series C | ¥120M | 3 | — | — | Detail |
| Mar 16, 2017 | Post-IPO Equity | ¥25M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
TOPGEN is funded by 4 investors.
Zhujijingkaichuangrong Touzi
and Zhuji Jingkai Chuangyou Guquan Jijin
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
|
|
— | Series C |
|
|
— | Series C |
|
|
— | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
